Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Northrop Grumman Corporation (NOC) vs UiPath Inc (PATH) Price & Performance

Northrop Grumman CorporationTrade
UiPath IncTrade

Price performance (Past 24H)

Key statistics

Northrop Grumman Corporation vs UiPath Inc — how do they compare? Northrop Grumman Corporation trades at $516.5 (market cap $73.16B), while UiPath Inc trades at $13.58 (market cap $7.26B). The key difference: Northrop Grumman Corporation is far larger — about 10.1× UiPath Inc's market cap, and Northrop Grumman Corporation pays a 1.92% dividend while UiPath Inc pays none. Which is the better fit depends on your goals.

NOCPATH
Market Cap
$73.16B$7.26B
Sector
IndustrialsTechnology
52-Week High
$768.02$19.29
52-Week Low
$496.02$9.38
Enterprise Value
$87.14B$6.05B
Dividend Yield
1.92%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Northrop Grumman Corporation

Northrop Grumman (NOC) trades at $518.58, up 0.7% with strong earnings beats in recent quarters. Technical indicators show a bearish trend with oversold RSI signals, while fundamentals remain solid with 10.48% net margin and 26.96% ROE. The company maintains a record $105 billion backlog and raised guidance after strong Q2 results, supported by rising defense spending globally.

NOC presents a compelling value with a 16.37 P/E below industry averages and a $618.43 consensus price target implying 19% upside. Risks include execution on massive contracts and defense budget volatility, but analyst sentiment is strongly bullish with 57% buy ratings. The stock offers defensive growth exposure amid geopolitical tensions.

UiPath Inc

UiPath (PATH) trades at $14.01, down 7.77% amid mixed signals. The stock is near its consensus price target low of $14.00. Revenue growth is improving, with 2025 revenue at $1.43 billion and a projected net profit margin of 21.03% for 2026. Technical indicators show a bearish near-term trend with RSI at oversold levels, while recent news highlights volatility following Q2 earnings.

The outlook is cautious; PATH shows fundamental improvement but faces execution risks and competitive pressure. Analyst consensus is predominantly Hold (70.84%), with a $17.38 price target suggesting modest upside. Key risks include slowing growth guidance and macroeconomic headwinds impacting software demand.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Northrop Grumman Corporation

Northrop Grumman is a defense contractor that is diversified across short-cycle and long-cycle businesses. The firm's segments include aeronautics, mission systems, defense services, and space systems. The company's aerospace segment creates the fuselage for the massive F-35 program and produces various piloted and autonomous flight systems. Mission systems creates a variety of sensors and processors for defense hardware. The defense systems segment is a long-range missile manufacturer. Finally, the company's space systems segment produces various space structures, sensors, and satellites.

Read more on NOC

About UiPath Inc

UiPath Inc creates an end-to-end platform that provides automation with user emulation at its core. Its platform is built to be used by employees throughout a company and to address a wide variety of use cases, from simple tasks to long-running, complex business processes. It generates revenue from the sale of licenses for its proprietary software, maintenance and support, and professional services. It generates a majority of the revenues from the US, followed by Romania and the rest of the world.

Read more on PATH